To further explore the expression relationship between IGF2BP3, GPX4, and NRF2, a multi-color immunohistochemistry (mIHC) assay was conducted using a glioma tumor tissue microarray (TMA) obtained from 60 clinical glioma patients’ samples. Here, IGF2BP3 is linked to neoplasm.